Oral Lactoferrin in HIV-1 Vertically Infected Children: An Observational Follow-up of Plasma Viral Load and Immune Parameters

Abstract

Lactoferrin (LF) is a mammalian iron-binding glycoprotein with antiviral effects. This preliminary study evaluated 6 months' LF (3 g/day, orally) treatment in 22 human immunodeficiency virus type 1 (HIV-1) vertically infected children. Plasma viral load and CD4+ cell counts were assessed every 3 months; before, during and after LF administration. No significant changes were observed during the pre-treatment period. By 6 months, mean (± SD) plasma viral load (log₁₀) declined from 4.54 (± 0.65) to 4.28 (± 0.60); median percentage CD4+ cell count increased from 21.5% to 24.5%. Two months after treatment discontinuation, mean plasma viral load did not differ significantly from baseline or month 6 levels, but the percentage CD4+ cell count remained significantly higher than the baseline value. LF plus antiretroviral (ARV) therapy was more effective at increasing CD4+ cell count than LF alone. None of the patients showed any new HIV-1-related symptoms at follow-up. LF might be a useful addition to ARV therapy, but further large-scale studies are required.

Keywords

Lactoferrin Antiretroviral drugs Human immunodeficiency virus Children

References

Viani

Gutteberg

Lathey

Spector

: Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS 1999; 13: 1273–1274.

Kanyshkova

Buneva

Nevinsky

: Lactoferrin and its biological function. Biochemistry 2001; 66: 1–7.

Lonnerdal

: Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003; 77: 1537S–1543S.

Arnold

Cole

McGhee

: A bactericidal effect for human lactoferrin. Science 1977; 197: 263–265.

Ajello

Greco

Giansanti

Massucci

Antonini

Valenti

: Anti-invasive activity of bovine lactoferrin towards group A streptococci. Biochem Cell Biol 2002; 80: 119–124.

Fernaud

Evans

: Lactoferrin: A multifunctional protein with antimicrobial properties. Mol Immunol 2003; 40: 395–405.

Pietrantoni

Di Biase

Tinari

Marchetti

Valenti

Seganti

: Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob Agents Chemother 2003; 47: 2688–2691.

Harmsen

Swart

de Bethune

Pauwels

De Clercq

The

: Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro J Infect Dis 1995; 172: 380–388.

Superti

Ammendolia

Valenti

Seganti

: Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med Microbiol Immunol (Berl) 1997; 186: 83–91.

10.

Baveye

Elass

Mazurier

Spik

Legrand

: Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999; 37: 281–286.

11.

Petschow

Talbot

Batema

: Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level. J Med Microbiol 1999; 48: 541–549.

12.

Puddu

Borghi

Gessati

Valenti

Belardelli

Seganti

: Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int J Biochem Cell Biol 1998; 30: 1055–1062.

13.

Semba

Miotti

Lan

Chiphangwi

Hoover

Dallabetta

: Maternal serum lactoferrin and vertical transmission of HIV. AIDS 1998; 12: 331–332.

14.

Centers for Disease Control and Prevention: 1994 revised classification system for human immunodeficiency virus infection in children under 13 years of age. Morb Mortal Wkly Rep 1994; 43: 1–10.